Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

AlzChem Group AG (ACT1)

Xetra
Currency in EUR
61.2000
-0.2000(-0.33%)
Closed
ACT1 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
60.200064.2000
52 wk Range
22.200064.8000
Key Statistics
Edit
Bid/Ask
60.20 / 61.20
Prev. Close
61.4
Open
63.2
Day's Range
60.2-64.2
52 wk Range
22.2-64.8
Volume
20.06K
Average Volume (3m)
9.36K
1-Year Change
144.62%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACT1 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
72.6800
Upside
+15.7325%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years

AlzChem Group AG Company Profile

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany.

Industry
Chemicals
Employees
1607
Market
Germany

Compare ACT1 to Peers and Sector

Metrics to compare
ACT1
Peers
Sector
Relationship
P/E Ratio
12.5x17.0x−0.1x
PEG Ratio
0.190.260.00
Price/Book
3.2x1.0x1.6x
Price / LTM Sales
1.1x0.6x1.3x
Upside (Analyst Target)
17.1%17.8%28.0%
Fair Value Upside
Unlock13.4%1.4%Unlock

Analysts' Recommendations

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 72.6750

(+18.75% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.93
Dividend Yield
1.95%
Industry Median 2.24%
Annualised payout
1.2000
Paid annually
5-Years Growth
+5.92%
Growth Streak

People Also Watch

5.700
HXCKk
-6.86%
41.6000
NB2
+6.80%
84.650
TLXGn
+1.68%
169.33
LOPE
-0.57%
18.74
ZTO
+0.43%

FAQ

What Is the AlzChem Group (ACT1) Stock Price Today?

The AlzChem Group stock price today is 61.20

What Stock Exchange Does AlzChem Group Trade On?

AlzChem Group is listed and trades on the Xetra stock exchange.

What Is the Stock Symbol for AlzChem Group?

The stock symbol for AlzChem Group is "ACT1."

Does AlzChem Group Pay Dividends? What’s The Current Dividend Yield?

The AlzChem Group AG dividend yield is 1.95%.

What Is the AlzChem Group Market Cap?

As of today, AlzChem Group market cap is 639.07M.

What is AlzChem Group Earnings Per Share?

The AlzChem Group EPS is 4.93.

What Is the Next AlzChem Group Earnings Date?

AlzChem Group will release its next earnings report on 28 Feb 2025.

From a Technical Analysis Perspective, Is ACT1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.